Radiological Images for Nasotracheal Tube Size Estimation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-10-25

Study Completion Date

2020-03-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This trial is planned to estimate the size of nasotracheal tube (NTT) by calculating the diameter of both nasal cavity in radiological images of nose (CT scan/MRI) at the level below the inferior turbinate and floor of nose in coronal planes. Smallest diameter will be considered to calculate the outer diameter of NTT, hence the size .

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Total Body Composition in Detection of Nutrition Depletion in Head and Neck Patients

NCT02854735

Head and Neck Neoplasms Dual-Energy X-Ray Absorptiometry Malnutrition

UNKNOWN

Trail Evaluating Carbon Ion Radiotherapy (3 GyE Per Fraction) for Locally Recurrent Nasopharyngeal Carcinoma

NCT02795195

Nasopharyngeal Carcinoma

COMPLETED PHASE1/PHASE2

A Pilot Trial of Image-Guided Adaptive Radiotherapy for Head and Neck Cancer

NCT00490282

Head and Neck Cancer Oropharyngeal Cancer

COMPLETED NA

Monitoring Skeletal Muscle Mass Using CBCT in Patients With H&N Cancer Undergoing Chemoradiotherapy

NCT05126095

Head and Neck Cancer Radiotherapy; Adverse Effect

UNKNOWN

Continuous Activity Monitoring During Fractionated Radiotherapy in Patients With Head and Neck, Lung, or Gastrointestinal Cancer

NCT02649569

Digestive System Carcinoma Head and Neck Carcinoma Lung Carcinoma

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The planned trial will estimate the size of nasotracheal tube (NTT) by calculating the diameter of both nasal cavity in radiological images of nose (CT scan/MRI) at the level below the inferior turbinate and floor of nose at different levels in coronal planes. Smallest diameter will be considered to calculate the outer diameter of NTT, hence the size. The side of nasotracheal intubation will be decided after view the radiological images and the estimated size of NTT will be used. Finally the ease of intubation and complications will be recorded.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nasotracheal Tube Passage Through Nasal Cavity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nasotracheal Intubation

side of nostril and size of endotracheal tube estimation for nasotracheal intubation will be done based on radiological imaging ( CT/MRI head)

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Malinckrodt flexometallic tube

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. patients requiring nasal intubation for oromaxillofacial surgeries

Exclusion Criteria

* 1\. Midface instability
2. Coagulopathy
3. Suspected basilar skull fractures
4. Large nasal polyps
5. Suspected nasal foreign bodies
6. Recent nasal surgery
7. History of frequent episodes of epistaxis
8. Prosthetic heart valves (increased risk of bacteremia during the insertion).
9. Patients with deranged liver and renal functions.

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes